The pharmacological management of erectile dysfunction

The inability to attain or maintain a penile erection sufficient for sexual intercourse is a common problem experienced by a third of men over the age of 40 years. Erectile dysfunction (ED) is a debilitating disease which can have profound psychological effects on personal relationships and the soci...

Full description

Saved in:
Bibliographic Details
Main Author: Andre Marais
Format: Article
Language:English
Published: AOSIS 2015-07-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4298
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849329822676811776
author Andre Marais
author_facet Andre Marais
author_sort Andre Marais
collection DOAJ
description The inability to attain or maintain a penile erection sufficient for sexual intercourse is a common problem experienced by a third of men over the age of 40 years. Erectile dysfunction (ED) is a debilitating disease which can have profound psychological effects on personal relationships and the social well-being of the affected individual. The diagnosis and evaluation of sexual dysfunction has been well described, and several validated algorithms are available to quantify the classification and severity. The International Index of Erectile Function and the Sexual Health Inventory for Men questionnaires are commonly used in the initial assessment of ED. Several risk factors have been linked to the pathophysiology of ED. Endothelial damage has been the focus of many recent studies. An evaluation of cardiovascular status, in addition to the administration of questionnaires to men with ED, might reduce mortality and improve sexual quality of life.
format Article
id doaj-art-0b41c0cab84f45b792e8c51a937390d3
institution Kabale University
issn 2078-6190
2078-6204
language English
publishDate 2015-07-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj-art-0b41c0cab84f45b792e8c51a937390d32025-08-20T03:47:09ZengAOSISSouth African Family Practice2078-61902078-62042015-07-0157410.4102/safp.v57i4.42983483The pharmacological management of erectile dysfunctionAndre Marais0Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of PretoriaThe inability to attain or maintain a penile erection sufficient for sexual intercourse is a common problem experienced by a third of men over the age of 40 years. Erectile dysfunction (ED) is a debilitating disease which can have profound psychological effects on personal relationships and the social well-being of the affected individual. The diagnosis and evaluation of sexual dysfunction has been well described, and several validated algorithms are available to quantify the classification and severity. The International Index of Erectile Function and the Sexual Health Inventory for Men questionnaires are commonly used in the initial assessment of ED. Several risk factors have been linked to the pathophysiology of ED. Endothelial damage has been the focus of many recent studies. An evaluation of cardiovascular status, in addition to the administration of questionnaires to men with ED, might reduce mortality and improve sexual quality of life.https://safpj.co.za/index.php/safpj/article/view/4298cardiovascular diseaseerectile dysfunctionphosphodiesterase-5 inhibitorsprostaglandintestosterone
spellingShingle Andre Marais
The pharmacological management of erectile dysfunction
South African Family Practice
cardiovascular disease
erectile dysfunction
phosphodiesterase-5 inhibitors
prostaglandin
testosterone
title The pharmacological management of erectile dysfunction
title_full The pharmacological management of erectile dysfunction
title_fullStr The pharmacological management of erectile dysfunction
title_full_unstemmed The pharmacological management of erectile dysfunction
title_short The pharmacological management of erectile dysfunction
title_sort pharmacological management of erectile dysfunction
topic cardiovascular disease
erectile dysfunction
phosphodiesterase-5 inhibitors
prostaglandin
testosterone
url https://safpj.co.za/index.php/safpj/article/view/4298
work_keys_str_mv AT andremarais thepharmacologicalmanagementoferectiledysfunction
AT andremarais pharmacologicalmanagementoferectiledysfunction